Immunological Characterization of Light Chain Recombinant Protein of Clostridium botulinum Type A

Publish Year: 1386
نوع سند: مقاله ژورنالی
زبان: English
View: 195

This Paper With 13 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-15-59_003

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and Objective: Botulinum neurotoxin type A, structurally consists of a ۵۰KD light chain and a ۱۰۰ KD heavy chain linked by a disulfide bond. The protein can further be divided into three functional domains of which catalytic domain corresponds to the light chain. In this research we aimed to produce recombinant catalytic domain in order to obtain a protective protein. Materials and Methods: Bacteria were grown in anaerobic conditions and genomic DNA was extracted by alkaline method. Following the gene coding a set of primers was designed and the catalytic domain was amplified through PCR. The PCR product was then cloned into three expression vectors namely pRSETA, pET۲۸a and pET۳۲a. The expressed protein was analyzed on SDS-PAGE and confirmed by ELISA and western blotting and then purified by affinity chromatography. Results: In this research the maximum expression was obtained at ۰.۵ mM IPTG,OD۶۰۰:۰.۶ and ۱۵ hours of induction at ۳۰˚C. The protein so expressed was purified by affinity coulmn chromatography .The antibody raised against recombinant protein could protect the rats by ۱۰۰ LD۵۰ . Discussion: Though the expression of AT- rich genes in E.coli system is low, we could obtain an appropriate level of expression in this study. The purification of recombinant protein in the early stages was elusive in the extreme by affinity chromatography due to the weak binding of histidine N-terminal to the column, howerer ۹۰% purification was achieved through modification of the technique. The antibody produced against this domain was less protective compared to that of binding domain.

Keywords:

Clostridium botulinum type A , Catalytic domain , PCR , Recombinant protein